Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (471-480 of 487) with videos related to

Pageof 49
Sort By:
Cancer Causes & Control : CCC|October 12, 2022
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion programCary A Presant, Kimlin Ashing, Sophia Yeung, et al.
JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With <i>EGFR</i>-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2014
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypesMichaela K Keck, Zhixiang Zuo, Arun Khattri, et al.
The Lancet. Oncology|September 8, 2012
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyD Ross Camidge, Yung-Jue Bang, Eunice L Kwak, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Cancer|August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Journal of Clinical Medicine|February 25, 2023
Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope ExperienceCary A Presant, Kimlin Ashing, Dan Raz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 49

Showing results (471-480 of 487) with videos related to

Sort By:
Pageof 49
Cancer Causes & Control : CCC|October 12, 2022
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion programCary A Presant, Kimlin Ashing, Sophia Yeung, et al.
JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With <i>EGFR</i>-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2014
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypesMichaela K Keck, Zhixiang Zuo, Arun Khattri, et al.
The Lancet. Oncology|September 8, 2012
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyD Ross Camidge, Yung-Jue Bang, Eunice L Kwak, et al.
The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Cancer|August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Journal of Clinical Medicine|February 25, 2023
Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope ExperienceCary A Presant, Kimlin Ashing, Dan Raz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingRitu R Gill, Anne S Tsao, Hedy L Kindler, et al.
Journal of Clinical Medicine|October 26, 2024
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell CarcinomaBridget E Crossman, Regan L Harmon, Kourtney L Kostecki, et al.
Pageof 49